Common Anti-Inflammatory drug could be new weapon against heart attacks
NCT ID NCT07349875
Summary
This large study is testing whether adding a low-dose anti-inflammatory drug called colchicine to standard heart medications can better prevent serious heart problems. It will involve about 3,800 adults with stable coronary artery disease who have plaque buildup in their arteries but no current severe blockages. The goal is to see if reducing inflammation with colchicine lowers the risk of future heart attacks, strokes, or the need for heart procedures over several years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing First Hospital
RECRUITINGNanjing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.